Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

The Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Can be Reduced

Juan Carlos Olivares-Gazca, María de Lourdes Pastelín-Martínez, Merittzel Abigail Montes-Robles, Moisés Manuel Gallardo-Pérez, Edgar Jared Hernández-Flores, Max Robles-Nasta, Daniela Sánchez-Bonilla, César Homero Gutierrez-Aguirre, Andres Gomez-De Leon, David Gomez-Almaguer, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Arguelles

Blood (2023) 142 (Supplement 1): 2173.

https://doi.org/10.1182/blood-2023-181489

Published: 2023

Journal Articles

Disparities in Phase 3 Leukemia Trials from the Last Decade: A Long Way to Go

Andres Noyola-Perez, Alejandra J. Osuna-Corrales, Manali I. Patel, Jorge Cortes, Lillian Sung, Juan C. Angulo-Lozano, Perla R. Colunga-Pedraza, David Gomez-Almaguer, Guillermo José Ruiz-Arguelles, Andres Gomez-De Leon

Blood (2023) 142 (Supplement 1): 494.

https://doi.org/10.1182/blood-2023-189576

Published: 2023

Journal Articles

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Blood (2023) 142 (Supplement 1): 3352.

https://doi.org/10.1182/blood-2023-185240

Published: 2023

Journal Articles

Autologous HSCT for Multiple Sclerosis Should be Done Early in the Course of the Disease

María de Lourdes Pastelín-Martínez, Moisés Manuel Gallardo-Pérez, Andres Gomez-De Leon, Juan Carlos Olivares-Gazca, Edgar Jared Hernández-Flores, Daniela Sánchez-Bonilla, Merittzel Abigail Montes-Robles, Max Robles-Nasta, Guillermo Ocaña-Ramm, Silvia Soto-Olvera, David Gomez-Almaguer, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Arguelles

Blood (2023) 142 (Supplement 1): 3593.

https://doi.org/10.1182/blood-2023-181433

Published: 2023

Journal Articles

Identification of Biomarkers As Predictors of Patient-Reported Outcomes in Persons with Multiple Sclerosis Given Autologous Hematopoietic Stem Cell Transplantation

Moisés Manuel Gallardo-Pérez, Javier Garcés-Eisele, Guillermo José Ruiz-Argüelles

Blood (2022) 140 (Supplement 1): 4855.

https://doi.org/10.1182/blood-2022-163765

Published: 2022

Journal Articles

Why Are Patients Not Getting a Graft? an Intent-to-Transplant Analysis in the Times of Universal Coverage and Haploidentical Donors

Yadith Karina Lopez-Garcia, Christianne Bourlon De Los Rios, Perla Rocio Colunga-Pedraza, Cesar Omar Vargas-Serafin, Alberto Vazquez Mellado de Larracoechea, Lourdes Gil-Flores, Nidia Moncada Saucedo, Moisés Manuel Gallardo-Pérez, David Gomez-Almaguer, Guillermo José Ruiz-Argüelles, Andres Gomez-De Leon

Blood (2022) 140 (Supplement 1): 2419–2420.

https://doi.org/10.1182/blood-2022-167805

Published: 2022

Journal Articles

Long-Term Results of the Treatment of Adolescents and Adults with Acute Lymphoblastic Leukemia with a Pediatric-Inspired Regimen Delivered on an Outpatient Basis: A Single Institution Experience

Elizabeth García-Villaseñor, Jorge E. Cortes, Oscar A. Reyes-Cisneros, José Antonio Fernández-Gutiérrez, Daniela Sánchez-Bonilla, Lorena Bojalil-Álvarez, Iván Murrieta-Álvarez, Guillermo José Ruiz-Delgado, Guillermo José Ruiz Argüelles

Blood (2022) 140 (Supplement 1): 11590–11591.

https://doi.org/10.1182/blood-2022-163602

Published: 2022

Journal Articles

Patient-Reported-Outcomes and Safety of Autologous Stem Cell Transplantation in Multiple Sclerosis: A Single Center Experience with the "Mexican Method" in 1300 Persons

Juan Carlos Olivares-Gazca, Daniela Sánchez-Bonilla, José Antonio Fernández-Gutiérrez, Oscar A. Reyes-Cisneros, Moisés Manuel Gallardo-Pérez, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Argüelles

Blood (2022) 140 (Supplement 1): 1178–1179.

https://doi.org/10.1182/blood-2022-163740

Published: 2022

Journal Articles

Hematopoietic Stem Cell Transplantation Activity for Lymphoma: A Multicentric Study By the Transplantation and Cellular Therapy Mexican Working Group

Perla R.R. Colunga-Pedraza, Andres Gomez-De Leon, Christianne Bourlon De Los Rios, Cesar Omar Vargas-Serafin, Myrna Patricia Pequeño Luevano, Lauro Fabian Amador, Carolina García-Castillo, Martha Alvarado, Guillermo José Ruiz-Argüelles, Alberto Olaya-Vargas, Samantha P. Peña-Lozano, Guadalupe González Villarreal, Elías Eugenio González López, Gabriela Cardoso Yah, Ivan Murrieta-Alvarez, Luis Mario Villela Martinez, David Gomez Almaguer

Blood (2022) 140 (Supplement 1): 5185–5187.

https://doi.org/10.1182/blood-2022-169096

Published: 2022

Journal Articles

Modifications to the "Classical" Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

Guillermo Jose Ruiz-Argüelles, Sr., MDFRCP. (GLASG) MACP, Juan Carlos Olivares Gazca, MD, Ivan Murrieta-Alvarez, MD, David Blumenkron-Marroquin, MD, Elias Eugenio Gonzalez-Lopez, MD, Alejandro Ruiz-Argüelles, MD, Guillermo Jose Ruiz-Delgado, Jr., MD, Andres Gomez De Leon, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 3290.

https://doi.org/10.1182/blood.V130.Suppl_1.3290.3290

Published: 2017

Journal Articles

Front-Line Treatment in Immune Thrombocytopenia Using Eltrombopag and High-Doses of Dexamethasone, Long-Term Follow-up

Olga Cantu Rodriguez, MD, Miguel Herrera-Rojas, MD, Andrea Garza-Acosta, MD, Cesar Homero Gutierrez Aguirre, Perla Rocio Colunga Pedraza, MD, Jose Jaime, MD, Guillermo Jose Ruiz-Argüelles, Sr., MDFRCP. (GLASG) MACP, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 4848.

https://doi.org/10.1182/blood.V130.Suppl_1.4848.4848

Published: 2017

NARROW

The Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Can be Reduced

Disparities in Phase 3 Leukemia Trials from the Last Decade: A Long Way to Go

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Autologous HSCT for Multiple Sclerosis Should be Done Early in the Course of the Disease

Identification of Biomarkers As Predictors of Patient-Reported Outcomes in Persons with Multiple Sclerosis Given Autologous Hematopoietic Stem Cell Transplantation

Why Are Patients Not Getting a Graft? an Intent-to-Transplant Analysis in the Times of Universal Coverage and Haploidentical Donors

Long-Term Results of the Treatment of Adolescents and Adults with Acute Lymphoblastic Leukemia with a Pediatric-Inspired Regimen Delivered on an Outpatient Basis: A Single Institution Experience

Patient-Reported-Outcomes and Safety of Autologous Stem Cell Transplantation in Multiple Sclerosis: A Single Center Experience with the "Mexican Method" in 1300 Persons

Hematopoietic Stem Cell Transplantation Activity for Lymphoma: A Multicentric Study By the Transplantation and Cellular Therapy Mexican Working Group

Modifications to the "Classical" Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

Front-Line Treatment in Immune Thrombocytopenia Using Eltrombopag and High-Doses of Dexamethasone, Long-Term Follow-up

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only